Risk Factors for CVD More Common in Postmenopausal Women Who Survived Breast Cancer
Researchers compared the development of specific CVD risk factors in postmenopausal women who survived breast cancer and women without history of breast cancer.
Researchers compared the development of specific CVD risk factors in postmenopausal women who survived breast cancer and women without history of breast cancer.
Older women with diabetes and cancer taking metformin saw an increase in survival.
Dose-dense adjuvant chemotherapy (every 2 weeks) offers improved survival without increasing the risk of treatment-induced early menopause compared with the standard interval (every 3 weeks) chemotherapy for premenopausal women with breast cancer.
Concurrent administration of triptorelin and chemotherapy was associated with higher long-term probability of ovarian function compared with chemotherapy alone among premenopausal women with either HR-positive or HR-negative breast cancer.
A reduction in endometrial cancer risk with oral bisphosphonate use in large cohort of postmenopausal women has been observed.
Women who survive cancer have more frequent, severe, and troubling hot flashes than women with menopausal symptoms, according to a recent study.
Greater height was linked with increased risk of all cancers and specific cancers at numerous sites,for postmenopausal women, per a recent study.
Early-stage breast cancer survivors may be able to relieve hot flashes by maintaining their weight.
Implementing an educational program for nurses designed specifically to address therapy-induced menopause in premenopausal women undergoing a blood or marrow transplant (BMT) would help improve patient outcomes, especially since few opportunities exist for in-depth conversations about this topic. That is the goal of a project presented at the Oncology Nursing Society 36th Annual Congress.
Alcohol consumption is associated with increased risk of breast cancer recurrence, especially in women who are postmenopausal or overweight, according to a study presented at the CTRC-AACR San Antonio Breast Cancer Symposium.